Inflammation  >>  cyclosporin A microemulsion  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cyclosporin A microemulsion / Generic mfg.
NCT01810926 / 2011-004730-34: T&B Depletion Non Malignant

Unknown status
2
130
Europe
polyclonal antibody, ATG S Fresenius, Rituximab, Mabthera, Treosulfan, Medac, Fludarabine, Fludara, Thiotepa, Tepadina, Cyclosporine A, Neoral, Methotrexate
Franco Locatelli, University of Milano Bicocca, medac GmbH, Fresenius AG
Graft Versus Host Disease
08/15
10/16
2005-000890-23: NO as an objective marker for inflammation in patients with interstitial cystitis treated with cyclosporine.

Completed
2
15
Europe
Sandimmun Neoral, Sandimmun Neoral, Sandimmun Neoral
Ingrid Ehrén
Interstitiell cystit
 
01/08

Download Options